Silexion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLXN and other ETFs, options, and stocks.About SLXN
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
CEOIlan Hadar
CEOIlan Hadar
Employees14
Employees14
HeadquartersRamat-Gan, Tel Aviv
HeadquartersRamat-Gan, Tel Aviv
Founded2008
Founded2008
Employees14
Employees14
SLXN Key Statistics
Market cap9.90M
Market cap9.90M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume79.51K
Average volume79.51K
High today$3.26
High today$3.26
Low today$2.65
Low today$2.65
Open price$2.75
Open price$2.75
Volume118.01K
Volume118.01K
52 Week high$63.45
52 Week high$63.45
52 Week low$2.13
52 Week low$2.13
Stock Snapshot
The current Silexion Therapeutics(SLXN) stock price is $3.26, with a market capitalization of 9.9M. The stock trades at a price-to-earnings (P/E) ratio of -0.13.
On 2025-12-05, Silexion Therapeutics(SLXN) stock traded between a low of $2.65 and a high of $3.26. Shares are currently priced at $3.26, which is +23.0% above the low and 0.0% below the high.
The Silexion Therapeutics(SLXN)'s current trading volume is 118.01K, compared to an average daily volume of 79.51K.
In the last year, Silexion Therapeutics(SLXN) shares hit a 52-week high of $63.45 and a 52-week low of $2.13.
In the last year, Silexion Therapeutics(SLXN) shares hit a 52-week high of $63.45 and a 52-week low of $2.13.
People also own
Based on the portfolios of people who own SLXN. This list is generated using Robinhood data, and it’s not a recommendation.